Rights and permissions
About this article
Cite this article
Ceftazidime dosage stepdown saves drug costs in febrile neutropenia. Pharmacoecon. Outcomes News 219, 7 (1999). https://doi.org/10.1007/BF03295162
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03295162